STUDIES ON HUMAN GLIOMA AND RAT PROSTATE ADENOCARCINOMA CELLS IN VITRO
人胶质瘤和大鼠前列腺腺癌细胞的体外研究
基本信息
- 批准号:3901561
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:adenocarcinoma biological response modifiers butyrates cell adhesion cell cell interaction cell population study cellular oncology combination cancer therapy dexamethasone dimethylsulfoxide glioma human tissue hyaluronate membrane activity mucopolysaccharides neoplasm /cancer chemotherapy neoplasm /cancer immunology neoplastic cell prostate neoplasms retinoate tissue /cell culture
项目摘要
Shedding of various products from the cell surface of cancer cells
may have an important role in loss of adhesion, metastasis,
generation of immune-blocking factors and other pathophysiologic
aspects of cancer (Black PH, NEJM. 303:1315. 1980). Human glioma
cells in tissue culture produce and shed in the media much greater
amounts of glycosaminoglycans (GAGs) than normal glial cells
(Glimelius et al Biochem J. 172:443, 1978). Glycosaminoglycans are
polyanionic compounds, usually bound covalently to a protein core.
They are a prominent component of the cell surface and are
implicated in cell-cell interaction. There is also evidence for
existence of hyaluronidase-sensitive protective coats on some
neoplastic cell lines including gliomas, and it has been suggested
that the protective GAG coat may impede the immune response an the
efficacy of chemotherapy. Our objective was to modify or prevent
the synthesis and shedding of GAGs in human glioma cells in
culture, and possibly to render them more susceptible to
chemotherapy and more immunologically responsive. For this purpose
we use, singly or in combination, the differentiating agents
dimethyl sulfoxide (DMSO), sodium butyrate, retinoic acid, and
dexamethasone. These agents are known to affect the synthesis of
GAGs in other systems. Similar studies were also conducted on cell
line PA III derived from a transplantable adenocarcinoma of the rat
prostrate gland. The cell line can reproduce the original tumor
type when innoculated into Loboud Wistar rats and makes it
feasible, if necessary, to extend our studies in vivo.
肿瘤细胞表面各种产物的脱落
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
G CONSTANTOPOULOS其他文献
G CONSTANTOPOULOS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('G CONSTANTOPOULOS', 18)}}的其他基金
OXIDATIVE METABOLISM IN INHERITED NEUROLOGICAL DISEASES AND MYCOPLASMAS
遗传性神经疾病和支原体中的氧化代谢
- 批准号:
3969019 - 财政年份:
- 资助金额:
-- - 项目类别:
STUDIES ON THE MECHANISM OF PATHOGENESIS OF THE MUCOPOLYSACCHARIDOSES
粘多糖症发病机制的研究
- 批准号:
3968972 - 财政年份:
- 资助金额:
-- - 项目类别:
STUDIES ON HUMAN GLIOMA AND RAT PROSTATE ADENOCARCINOMA CELLS IN VITRO
人胶质瘤和大鼠前列腺腺癌细胞的体外研究
- 批准号:
3922566 - 财政年份:
- 资助金额:
-- - 项目类别:
OXIDATIVE METABOLISM IN INHERITED NEUROLOGICAL DISEASES AND IN MOLLICUTES
遗传性神经疾病和软体中的氧化代谢
- 批准号:
3901560 - 财政年份:
- 资助金额:
-- - 项目类别:
STUDIES ON THE MECHANISM OF PATHOGENESIS OF THE MUCOPOLYSACCHARIDOSES
粘多糖症发病机制的研究
- 批准号:
4696879 - 财政年份:
- 资助金额:
-- - 项目类别:
OXIDATIVE METABOLISM IN INHERITED NEUROLOGICAL DISEASES AND IN MOLLICUTES
遗传性神经疾病和软体中的氧化代谢
- 批准号:
3922561 - 财政年份:
- 资助金额:
-- - 项目类别:
OXIDATIVE METABOLISM IN INHERITED NEUROLOGICAL DISEASES AND MYCOPLASMAS
遗传性神经疾病和支原体中的氧化代谢
- 批准号:
4696940 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
Development of biological response modifiers of neurotrophins and their receptors
神经营养素及其受体生物反应调节剂的开发
- 批准号:
171953 - 财政年份:2008
- 资助金额:
-- - 项目类别:
Operating Grants
Collection, Storage, Advertisements, & Distribut of Biological Response Modifiers
收藏、保管、广告、
- 批准号:
7789037 - 财政年份:2006
- 资助金额:
-- - 项目类别:
Collection, Storage, Advertisements, & Distribut of Biological Response Modifiers
收藏、保管、广告、
- 批准号:
8089733 - 财政年份:2006
- 资助金额:
-- - 项目类别:
Design and development of biological response modifiers
生物反应调节剂的设计和开发
- 批准号:
14103018 - 财政年份:2002
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (S)
Enhancement of PDT Using Biological Response Modifiers
使用生物反应调节剂增强 PDT
- 批准号:
7624158 - 财政年份:2001
- 资助金额:
-- - 项目类别:
Enhancement of PDT Using Biological Response Modifiers
使用生物反应调节剂增强 PDT
- 批准号:
7867872 - 财政年份:2001
- 资助金额:
-- - 项目类别:
ENHANCEMENT OF PDT USING BIOLOGICAL RESPONSE MODIFIERS
使用生物反应调节剂增强 PDT
- 批准号:
6616667 - 财政年份:2001
- 资助金额:
-- - 项目类别:
Enhancement of PDT Using Biological Response Modifiers
使用生物反应调节剂增强 PDT
- 批准号:
7440233 - 财政年份:2001
- 资助金额:
-- - 项目类别:
ENHANCEMENT OF PDT USING BIOLOGICAL RESPONSE MODIFIERS
使用生物反应调节剂增强 PDT
- 批准号:
6758547 - 财政年份:2001
- 资助金额:
-- - 项目类别:
ENHANCEMENT OF PDT USING BIOLOGICAL RESPONSE MODIFIERS
使用生物反应调节剂增强 PDT
- 批准号:
6261215 - 财政年份:2001
- 资助金额:
-- - 项目类别: